Publisher: Icon Group International, Inc.
Category: Oncology/Hematology

Oncology/Hematology market research reports by Icon Group International, Inc.

(187 reports matching your criteria)
    • The 2025-2030 World Outlook for Targeted Therapy Liver Cancer Drugs

      The 2025-2030 World Outlook for Targeted Therapy Liver Cancer Drugs This study covers the world outlook for targeted therapy liver cancer drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country ... Read More

    • The 2025-2030 World Outlook for Non-Small Cell Lung Cancers

      The 2025-2030 World Outlook for Non-Small Cell Lung Cancers This study covers the world outlook for non-small cell lung cancers across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in ... Read More

    • The 2025-2030 World Outlook for Non-Melanoma Skin Cancers

      The 2025-2030 World Outlook for Non-Melanoma Skin Cancers This study covers the world outlook for non-melanoma skin cancers across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in mill ... Read More

    • The 2025-2030 World Outlook for Noninvasive Cancer Diagnostics

      The 2025-2030 World Outlook for Noninvasive Cancer Diagnostics This study covers the world outlook for noninvasive cancer diagnostics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in questio ... Read More

    • The 2025-2030 World Outlook for Lymphoma Treatments

      The 2025-2030 World Outlook for Lymphoma Treatments This study covers the world outlook for lymphoma treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. ... Read More

    • The 2025-2030 World Outlook for Malignant Melanoma Treatments

      The 2025-2030 World Outlook for Malignant Melanoma Treatments This study covers the world outlook for malignant melanoma treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question ... Read More

    • The 2025-2030 World Outlook for Bile Duct Cancer (Cholangiocarcinoma) Treatments

      The 2025-2030 World Outlook for Bile Duct Cancer (Cholangiocarcinoma) Treatments This study covers the world outlook for bile duct cancer (cholangiocarcinoma) treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings ... Read More

    • The 2025-2030 World Outlook for Alkylating Gynaecological Cancer Drugs

      The 2025-2030 World Outlook for Alkylating Gynaecological Cancer Drugs This study covers the world outlook for alkylating gynaecological cancer drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the co ... Read More

    • The 2025-2030 World Outlook for Cancer Cachexia

      The 2025-2030 World Outlook for Cancer Cachexia This study covers the world outlook for cancer cachexia across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars ... Read More

    • The 2025-2030 World Outlook for Interventional Oncology Devices

      The 2025-2030 World Outlook for Interventional Oncology Devices This study covers the world outlook for interventional oncology devices across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in quest ... Read More

    • The 2025-2030 World Outlook for In Vitro Colorectal Cancer Testing

      The 2025-2030 World Outlook for In Vitro Colorectal Cancer Testing This study covers the world outlook for in vitro colorectal cancer testing across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in ... Read More

    • The 2025-2030 World Outlook for Colorectal Cancer Treatments

      The 2025-2030 World Outlook for Colorectal Cancer Treatments This study covers the world outlook for colorectal cancer treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (i ... Read More

    • The 2025-2030 World Outlook for Granulocyte Colony Stimulating Factor (G-CSF) Cancer Supportive Care

      The 2025-2030 World Outlook for Granulocyte Colony Stimulating Factor (G-CSF) Cancer Supportive Care This study covers the world outlook for granulocyte colony stimulating factor (g-CSF) cancer supportive care across more than 190 countries. For each year reported, estimates are given for the latent ... Read More

    • The 2025-2030 World Outlook for Cancer Diagnostics Laboratory Tests

      The 2025-2030 World Outlook for Cancer Diagnostics Laboratory Tests This study covers the world outlook for cancer diagnostics laboratory tests across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country ... Read More

    • The 2025-2030 World Outlook for Pancreatic Cancer Drugs

      The 2025-2030 World Outlook for Pancreatic Cancer Drugs This study covers the world outlook for pancreatic cancer drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions ... Read More

    • The 2025-2030 World Outlook for Pap Smear Tests for Cervical Cancer Diagnostic Testing

      The 2025-2030 World Outlook for Pap Smear Tests for Cervical Cancer Diagnostic Testing This study covers the world outlook for pap smear tests for cervical cancer diagnostic testing across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential indust ... Read More

    • The 2025-2030 World Outlook for Veterinary Oncology

      The 2025-2030 World Outlook for Veterinary Oncology This study covers the world outlook for veterinary oncology across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. ... Read More

    • The 2025-2030 World Outlook for Cancer Immunotherapy Monoclonal Antibodies

      The 2025-2030 World Outlook for Cancer Immunotherapy Monoclonal Antibodies This study covers the world outlook for cancer immunotherapy monoclonal antibodies across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), fo ... Read More

    • The 2025-2030 World Outlook for Cancer Supportive Care

      The 2025-2030 World Outlook for Cancer Supportive Care This study covers the world outlook for cancer supportive care across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions o ... Read More

    • The 2025-2030 World Outlook for Cancer Supportive Care Drugs

      The 2025-2030 World Outlook for Cancer Supportive Care Drugs This study covers the world outlook for cancer supportive care drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (i ... Read More

    • The 2025-2030 World Outlook for Cancer Testing-Screening

      The 2025-2030 World Outlook for Cancer Testing-Screening This study covers the world outlook for cancer testing-screening across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millio ... Read More

    • The 2025-2030 World Outlook for Head and Neck Cancers

      The 2025-2030 World Outlook for Head and Neck Cancers This study covers the world outlook for head and neck cancers across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of ... Read More

    • The 2025-2030 World Outlook for Cancer Registry Software

      The 2025-2030 World Outlook for Cancer Registry Software This study covers the world outlook for cancer registry software across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millio ... Read More

    • The 2025-2030 World Outlook for Cancer Screenings

      The 2025-2030 World Outlook for Cancer Screenings This study covers the world outlook for cancer screenings across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dol ... Read More

    • The 2025-2030 World Outlook for Cancer Specialty Hospitals

      The 2025-2030 World Outlook for Cancer Specialty Hospitals This study covers the world outlook for cancer specialty hospitals across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in mi ... Read More

1 2 3 4 5 6 7 8

Research Assistance

Live help

Join Alert Me Now!

Sign Up

Find out more on our blog
Cookie Settings